Pluristem Therapeutics PSTI
$ 1.03
-1.9%
Annual report 2024
added 09-18-2024
Country |
Israel |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Yaky Yanay |
Employees in the company |
146 |
Shares |
5.24 M |
Market Cap[1] |
$ 33.3 M |
EBITDA (LTM) |
$ -32.2 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.